Table 1 Disorders detectable by EpiSign v2.
From: Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders
Disease/disorder | Causative gene(s)/region | New in EpiSign V2 | Validation cohort positives | Clinical cohort positives |
---|---|---|---|---|
É‘-thalassemia/mental retardation X-linked syndrome (ATR-X) | ATRX (301404) | No | 2 | 4 |
Autism, susceptibility to, 18 (AUT18) | CHD8 (610528) | Yes | 6 | 3 |
BAFopathies: Coffin–Siris (CSS1–4, and 8) and Nicolaides–Baraitser (NCBRS) syndromes | ARID1B (135900), ARID1A (614607), SMARCB1 (614608), SMARCA4 (614609), SMARCC2 (618362), SMARCA2 (601358) | ARID1A, SMARCC2 | 28 | 10 |
Blepharophimosis intellectual disability syndrome, SMARCA2 type | SMARCA2 (OMIM not available, PMID: 32694869) | Yes | 2 | Â |
Börjeson–Forssman–Lehmann syndrome (BFLS) | PHF6 (301900) | Yes | 1 |  |
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant (ADCADN) | DNMT1 (604121) | No | Â | Â |
CHARGE syndrome | CHD7 (214800) | No | 6 | 4 |
Cornelia de Lange syndrome (CdLS) | NIPBL (122470), RAD21 (614701), SMC3 (610759), SMC1A (300590) | No | 11 | 6 |
Down syndrome | Trisomy 21 (190685) | No | 1 | Â |
Epileptic encephalopathy, childhood-onset (EEOC) | CHD2 (615369) | Yes | 1 | Â |
Floating Harbor syndrome (FLHS) | SRCAP (136140) | No | Â | Â |
Genitopatellar syndrome (GTPTS) and Ohdo syndrome, SBBYSS variant (SBBYSS) | KAT6B (606170; 603736) | No | 3 | 2 |
Helsmoortel–van der Aa syndrome (HVDAS)a | ADNP (615873) | No | 9 | 2 |
Hunter–McAlpine syndrome (HMA) | Chr5q35-qter duplication (601379) | Yes |  |  |
Immunodeficiency–centromeric instability–facial anomalies syndrome (ICF)b | DNMT3B (242860), CDCA7 (616910), ZBTB24 (614069), HELLS (616911) | Yes |  |  |
Kabuki syndrome | KMT2D (147920), KDM6A (300867) | KDM6A | 12 | 5 |
Kleefstra syndrome | EHMT1 (610253) | Yes | 2 | 2 |
Koolen–de Vries syndrome (KDVS) | KANSL1 (610443) | Yes | 5 |  |
Mental retardation, autosomal dominant 23 (MRD23) | SETD5 (615761) | Yes | 4 | Â |
Mental retardation, autosomal dominant 51 (MRD51) | KMT5B (617788) | Yes | Â | Â |
Mental retardation, X-linked 93 (MRD93) | BRWD3 (300659) | Yes | 1 | 1 |
Mental retardation, X-linked 97 (MRD97) | ZNF711 (300803) | Yes | Â | 1 |
Mental retardation, X-linked syndromic, Nascimento-type (MRXSN) | UBE2A (300860) | Yes | 1 | Â |
Mental retardation, X-linked, Snyder–Robinson type (MRXSSR) | SMS (309583) | Yes |  | 1 |
Mental retardation, X-linked, syndromic, Claes–Jensen syndrome (MRXSCJ) | KDM5C (300534) | No | 6 | 1 |
PCR2 complex (Weaver (WVS) and Cohen–Gibson (COGIS) | EZH2 (277590), EED (617561) | Yes |  |  |
Rahman syndrome (RMNS) | HIST1H1E (617537) | Yes | Â | Â |
Rubinstein–Taybi syndrome (RSTS) | CREBBP (180849), EP300 (613684) | Yes | 2 | 3 |
SETD1B-related syndrome | SETD1B (619000) | Yes | Â | 1 |
Sotos syndrome | NSD1 (117500) | No | 8 | 4 |
Tatton–Brown–Rahman syndrome (TBRS) | DNMT3A (615879) | Yes | 1 | 1 |
Wiedemann–Steiner syndrome (WDSTS) | KMT2A (605130) | Yes | 3 | 2 |
Williams–Beuren deletion syndrome (WBS) and Williams–Beuren regions duplication syndrome (Dup7)c | 7q11.23 deletion (194050)/duplication (609757) | No | 2 |  |
Wolf–Hirschhorn syndrome (WHS) | Chr4p16.13 deletion (194190) | Yes |  |  |
Fragile X syndrome (FXS) | TNR/FMR1 (300624) | No | 6 | Â |
Mental retardation, FRA12A type | TNR/DIP2B (136630) | No | Â | 1 |
Angelman syndrome (AS) | ID/UBE3A (105830) | No | 6 | 1 |
Prader–Willi syndrome | ID/15q11 (SNRPN, NDN) (176270) | No | 3 |  |
Silver–Russell syndrome 1 (SRS1) | ID/11p15.5 (180860) | No | 5 | 1 |
Beckwith–Wiedemann syndrome (BWS) | ID/11p15 (ICR1, KCNQ1OT1, CDKN1C) (130650) | No | 4 |  |
Silver–Russell syndrome 2 (SRS2) | ID/7p11.2 (180860) | No |  |  |
Temple syndrome | ID/14q32 (616222) | No | Â | Â |
Kagami–Ogatta syndrome (KOS) | ID/14q32 (608149) | No | 2 |  |